Effects of lidocaine administration on hemodynamics and cytokine responses to endotoxemia in rabbits

Critical Care Medicine

Volumn 28, Issue 3, 2000, Pages 755-759

  Taniguchi, Takumi ^a   Shibata, Keizo ^a   Yamamoto, Ken ^a   Mizukoshi, Yuzo ^a   Kobayashi, Tsutomu ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Cardiac output; Cytokine; Endotoxemia; Endotoxin; Hemodynamics; Interleukin 6; Interleukin 8; Lidocaine; Rabbit; Sepsis

Indexed keywords

CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; LIDOCAINE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD GAS ANALYSIS; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG INHIBITION; ENDOTOXEMIA; HEART OUTPUT; HEART RATE; HEMODYNAMICS; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SYSTEMIC VASCULAR RESISTANCE;

EID: 0034023004     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200003000-00025     Document Type: Article

References (16)

1. 1. Wakabayashi G, Gelfard JA, Jung WK, et al: Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock like state and tissue injury in rabbits without endotoxemia: Comparison to Escherichia coli. J Clin Invest 1991; 87:1925-1935
2. 2. Casey LC, Balk RA, Bone RC: Plasma cytokines and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993; 119:771-778
3. 3. Marty C, Misset B, Tamion F, et al: Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 1994; 22: 673-679
4. 4. Kuhns DB, Alvord WC, Gallin JI: Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. J Infect Dis 1995; 171:145-152
5. 5. Damas P, Reuter A, Gysen P, et al: Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 1989; 17:975-978
6. 6. Natanson C, Eichenholz PW, Danner RL, et al: Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 1989; 169:823-832
7. 7. Taniguchi T, Shibata K, Yamamoto K, et al: Lidocaine attenuates the hypotensive and inflammatory responses to endotoxemia in rabbits. Crit Care Med 1996; 24:642-646
8. 8. Reuven P, Heather NP, Stephen DS, et al: Glycosylated recombinant human tumor necrosis factor binding protein-1 reduces mortality, shock, and production of tumor necrosis factor in rabbit Escherichia coli sepsis. Crit Care Med 1995; 23:1080-1089
9. 9. Lambalgen AA, Bronsveld W, Bos GC, et al: Distribution of cardiac output, oxygen consumption and lactate production in canine endotoxin shock. Cardiovasc Res 1984; 18: 195-205
10. 10. Forfia PR, Zhang X, Ochoa M, et al: Relationship between plasma NOx and cardiac and vascular dysfunction after LPS injection in anesthetized dogs. Am J Physiol 1998; 274: H193-H201
11. 11. Rubin LJ, Keller RS, Parker JL, et al: Contractile dysfunction of ventricular myocytes isolated from endotoxemic guinea pigs. Shock 1994; 2:113-120
12. 2+ in cardiac myocytes. Circ Res 1997; 81: 1011-1020
13. 13. Minghini A, Britt LD, Hill MA: Interleukin-1 and interleukin-6 mediated skeletal muscle arteriolar vasodilation: In vitro versus in vivo studies. Shock 1998; 9:210-215
14. 14. Herbertson MJ, Werner HA, Walley KR: Nitric oxide synthase inhibition partially prevents decreased LV contractility during endotoxemia. Am J Physiol 1996; 270: H1970-H1984
15. 15. Sinclair R, Eriksson AS, Gretzer C, et al: Inhibitory effects of amide local anaesthetics on stimulus-induced human leukocyte metabolic activation, LTB4 release and IL-1 secretion in vitro. Acta Anaesthesiol Scand 1993; 37:159-165
16. 16. Mikawa K, Maekawa N, Nishina K, et al: Effect of lidocaine pretreatment on endotoxin-induced lung injury in rabbits. Anesthesiology 1994; 81:689-699